BostonSight Increases Accessibility of Higher Order Abberation (HOA) Correction in Vision Care

NEEDHAM, Mass. - Oct. 20, 2020 - PRLog -- BostonSight^®, a nonprofit eye healthcare organization and research center dedicated to saving sight and improving quality of life, announced today their HOA Collaborator Program, partnering with eyecare professionals to offer SmartSight™ higher order aberration (HOA) correction technology in specialty lenses.

BostonSight has been actively treating patients with HOA technology for more than 20 years, starting with front surface eccentricity features in their lenses and moving forward to full wavefront correction. The organization is expanding access to this innovative technology to help additional patients who could benefit.

HOAs are imperfections in the ocular visual system that result in visually significant distortions, such as glare, halos, blurring, starburst patterns, double vision or difficulty seeing at night. Typical contact lenses or glasses are ineffective at correcting these aberrations, however BostonSight PROSE™ devices and BostonSight SCLERAL lenses with the addition of SmartSight HOA correcting technology have shown promising results.

BostonSight's HOA correcting technology uses an open-aberrometer platform along with a simple step-by-step guide and consultation to help novice to experienced practitioners harness the benefits of HOA correction and improve patient vision.

"We are excited to collaborate with our BostonSight PROSE and BostonSight SCLERAL networks to further enhance the HOA technology that BostonSight has offered for years," said Dr. Daniel Brocks, BostonSight's Chief Medical Officer. "Our partners and colleagues are experts in patient care and have vast knowledge about patients' vision challenges. Through collaboration and our open-aberrometer platform, together we can increase understanding and accessibility to HOA correction, helping more people see clearly."

"BostonSight advances specialty lens technology through our academic medical center model, leveraging 30 years of scleral lens design and training, an on-site patient clinic, and an active research center," said Sara Yost, BostonSight President and CEO. "This model allows BostonSight to continually learn from patient and practitioner feedback, identify needs, and develop technologies and treatments that lead to better patient care and outcomes. By joining the HOA Collaborator Program, practitioners can help push the industry forward."

BostonSight PROSE and SCLERAL network partners, or other Optometrists or Ophthalmologists who have access to an aberrometer and are interested in joining the HOA Collaborator Program may inquire at https://www.bostonsight.org/hoa-collaborator-program/.  At this time, there is no additional charge to practitioners to utilize SmartSight HOA technology with any BostonSight lens order.

To join the BostonSight SCLERAL Partner Network, join at no cost at www.bostonsightscleral.org/get-started.

About BostonSight^®
BostonSight has saved the sight of thousands of individuals suffering from ocular surface disease, corneal disease, injury, or damage with BostonSight PROSE™ treatment. Founded in 1992, the Needham, MA Center of Excellence includes a clinic, research center, state-of-the-art FDA-certified and ISO-compliant manufacturing lab, and patient and family support center.  BostonSight SCLERAL was launched in 2017 to expand access to global scleral lens technology.  Eye care practitioners achieve a fast, effective scleral lens fit that provides optimal vision and comfort for patients while attaining long-term eye health.  SCLERAL^IG is the newest innovation in BostonSight's portfolio, using image topography to map the eye for a truly custom scleral lens fit. BostonSight envisions a world where no one suffers loss of sight from corneal irregularities or ocular surface disease. Learn more at www.bostonsight.org.